NDC 63323-464-01 - SENSORCAINE MPF
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 63323-464
- Requested NDC
- 63323-464-01
- Package NDCs from labels
- 63323-464-08, 63323-464-38, 63323-464-02, 63323-464-37, 63323-464-03, 63323-464-31, 63323-464-01, 63323-464-17, 63323-464-09, 63323-464-39
- Manufacturer
- Fresenius Kabi USA, LLC
- Effective date
- 2024-11-18
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| SENSORCAINE MPF - Fresenius Kabi USA, LLC | Fresenius Kabi USA, LLC | 2024-11-18 | HUMAN PRESCRIPTION DRUG LABEL |
| SENSORCAINE - Fresenius Kabi USA, LLC | Fresenius Kabi USA, LLC | 2024-10-15 | HUMAN PRESCRIPTION DRUG LABEL |
| Sensorcaine MPF - Fresenius Kabi USA, LLC | Fresenius Kabi USA, LLC | 2023-05-12 | HUMAN PRESCRIPTION DRUG LABEL |
| SENSORCAINE MPF - Fresenius Kabi USA, LLC | Fresenius Kabi USA, LLC | 2022-08-17 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 63323-464-02 | SENSORCAINEMPF | 30 mL in 1 VIAL, SINGLE-DOSE | INJECTION, SOLUTION | 30 | 10 | |
| 63323-464-03 | SENSORCAINEMPF | 30 mL in 1 VIAL, SINGLE-DOSE | INJECTION, SOLUTION | 30 | 10 | |
| 63323-464-31 | SENSORCAINEMPF | 5 in 1 BOX | INJECTION, SOLUTION | 5 | 10 | |
| 63323-464-37 | SENSORCAINEMPF | 25 in 1 TRAY | INJECTION, SOLUTION | 25 | 10 | |
| 63323-464-01 | SensorcaineMPF | 10 mL in 1 VIAL, SINGLE-DOSE | INJECTION, SOLUTION | 10 | 7 | |
| 63323-464-17 | SensorcaineMPF | 25 in 1 TRAY | INJECTION, SOLUTION | 25 | 7 | |
| 63323-464-08 | SENSORCAINEMPF | 10 mL in 1 VIAL, SINGLE-DOSE | INJECTION, SOLUTION | 10 | 1 | |
| 63323-464-09 | SENSORCAINEMPF | 30 mL in 1 VIAL, SINGLE-DOSE | INJECTION, SOLUTION | 30 | 1 | |
| 63323-464-38 | SENSORCAINEMPF | 25 in 1 TRAY | INJECTION, SOLUTION | 25 | 1 | |
| 63323-464-39 | SENSORCAINEMPF | 25 in 1 TRAY | INJECTION, SOLUTION | 25 | 1 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 63323-464 | SENSORCAINE (BUPIVACAINE HYDROCHLORIDE) INJECTION, SOLUTION SENSORCAINE MPF (BUPIVACAINE HYDROCHLORIDE AND EPINEPHRINE BITARTRATE) INJECTION, SOLUTION [FRESENIUS KABI USA, LLC] | 10 | Current NDC, Legacy NDC, 4 package rows | 20241031_eb6d8fee-def4-4c96-9972-695e8cea8ea8.zip |
| 63323-464 | SENSORCAINE MPF (BUPIVACAINE HYDROCHLORIDE) INJECTION, SOLUTION [FRESENIUS KABI USA, LLC ] | 7 | Current NDC, Legacy NDC, 2 package rows | 20230630_e700eb7b-8b14-49c9-96b2-331f18776e45.zip |
| 63323-464 | SENSORCAINE MPF (BUPIVACAINE HYDROCHLORIDE AND EPINEPHRINE BITARTRATE) INJECTION, SOLUTION SENSORCAINE MPF (BUPIVACAINE HYDROCHLORIDE) INJECTION, SOLUTION [FRESENIUS KABI USA, LLC] | 1 | Current NDC, Legacy NDC, 2 package rows | 20241012_dcf3c0ad-9eb8-4ee7-96df-d0db7ff23175.zip |
| 63323-464 | SENSORCAINE MPF (BUPIVACAINE HYDROCHLORIDE) INJECTION, SOLUTION [FRESENIUS KABI USA, LLC] | 1 | Current NDC, Legacy NDC, 2 package rows | 20241222_b6bfc04a-1868-4630-9ca1-8c027af97ce3.zip |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 63323-464-01 | ML - Milliliter | 63323-464 | a95009d7-4c76-43d9-a031-32de3733f023 | 1 | 2021-09-07 |
| 63323-464-02 | ML - Milliliter | 63323-464 | ed5d75df-0557-4de0-be0d-b650577eb9cd | 1 | 2022-02-07 |
| 63323-464-08 | ML - Milliliter | 63323-464 | b9775b1b-7b08-44ff-a98c-ff02d3683946 | 1 | 2025-01-14 |
| 63323-464-09 | ML - Milliliter | 63323-464 | 7fec3893-88a9-4e8e-93c9-ff52085ce489 | 1 | 2024-11-05 |
| 63323-464-17 | ML - Milliliter | 63323-464 | 018101d1-b391-4d43-a136-957d34adf595 | 1 | 2012-07-24 |
| 63323-464-31 | ML - Milliliter | 63323-464 | fd4dff38-e949-491f-920d-8ed9e60e7ac8 | 1 | 2012-07-24 |
| 63323-464-33 | ML - Milliliter | 63323-464 | f9592b4f-7114-4d9a-a869-a2d296abbd2d | 1 | 2012-07-24 |
| 63323-464-37 | ML - Milliliter | 63323-464 | 77835e45-e7a7-46f2-888e-7c68cad0a54c | 1 | 2012-07-24 |
| 63323-464-38 | ML - Milliliter | 63323-464 | 8d957fa6-2077-461b-b74f-6e6b6839b4e2 | 1 | 2025-01-14 |
| 63323-464-39 | ML - Milliliter | 63323-464 | 3e1e097f-d34f-4a38-90d4-c2c7a9797684 | 1 | 2024-11-05 |
DailyMed Socrata Ingredients#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| PEG 3350, sodium chloride, sodium bicarbonate and potassium chloride | POLYETHYLENE GLYCOL 3350, SODIUM CHLORIDE, SODIUM BICARBONATE, POTASSIUM CHLORIDE | Wilshire Pharmaceuticals, Inc. | 4e442a72-b13b-4869-8a1d-59356095b091 | 2026-04-14 | Warnings, Adverse reactions | 451W47IQ8X |
| Bupivacaine Hydrochloride | BUPIVACAINE HYDROCHLORIDE | Cardinal Health 107, LLC | 8f8f4ece-de78-4c13-8d9f-c3bb7053019d | 2026-04-14 | Boxed warning, Warnings, Adverse reactions | 1725082 7TQO7W3VT8 |
| BUPIVACAINE HYDROCHLORIDE | BUPIVACAINE HYDROCHLORIDE | Hospira, Inc. | bb44c7e1-d911-4788-908f-09b7b271969b | 2026-04-14 | Boxed warning, Warnings, Adverse reactions | 1725078 1725082 7TQO7W3VT8 |
| SODIUM CHLORIDE 1 GRAM | SODIUM CHLORIDE | Gendose Pharmaceuticals, LLC | ce988ae5-61c6-4324-90e1-a94c8a54d0d0 | 2026-04-13 | Warnings | 451W47IQ8X |
| Quantum Resonance | ALCOHOLUS, ALUMINA SILICATA, ANACARDIUM ORIENTALE, AQUA MARINA, BAPTISIA TINCTORIA, CANDIDA ALBICANS, COLLAGEN, DNA, LAVANDULA OFFICINALIS, MEDULLA OSSIS SUIS, NATRUM MURIATICUM, NATRUM PHOSPHORICUM, NUX MOSCHATA, PHOSPHORUS, QUARTZ, SILICEA, TELA ARANEA, VALERIANA OFFICINALIS, VISCUM ALBUM | Deseret Biologicals, Inc. | f94a10bd-1c40-42c7-b458-b58070614549 | 2026-04-10 | Warnings | 451W47IQ8X |
| Quantum Resonance | ALCOHOLUS, ALUMINA SILICATA, ANACARDIUM ORIENTALE, AQUA MARINA, BAPTISIA TINCTORIA, CANDIDA ALBICANS, COLLAGEN, DNA, LAVANDULA OFFICINALIS, MEDULLA OSSIS SUIS, NATRUM MURIATICUM, NATRUM PHOSPHORICUM, NUX MOSCHATA, PHOSPHORUS, QUARTZ, SILICEA, TELA ARANEA, VALERIANA OFFICINALIS, VISCUM ALBUM | Deseret Biologicals, Inc. | 1467111a-bef6-473d-b7f2-3309a9bb72ce | 2026-04-10 | Warnings | 451W47IQ8X |
| H-Focus Formula | AGNUS CASTUS, AVENA SATIVA, BARYTA CARBONICA, IGNATIA AMARA, LYCOPODIUM CLAVATUM, NATRUM CARBONICUM, NATRUM MURIATICUM, PHOSPHORICUM ACIDUM, SILICEA, ZINCUM METALLICUM | Healing Natural Oils LLC | 4ee42911-3064-7f55-e063-6294a90abcc7 | 2026-04-07 | Warnings | 451W47IQ8X |
| H-Mood Formula | AGRIMONIA EUPATORIA, FLOS, ANACARDIUM ORIENTALE, AURUM METALLICUM, AVENA SATIVA, BORAGO OFFICINALIS, CAPSICUM ANNUUM, CARPINUS BETULUS, FLOS, CIMICIFUGA RACEMOSA, CINCHONA OFFICINALIS, HYPERICUM PERFORATUM, KALI BROMATUM, LARIX DECIDUA, FLOS, NATRUM CARBONICUM, NATRUM MURIATICUM, NATRUM SULPHURICUM, PHOSPHORICUM ACIDUM, PHOSPHORUS, PULSATILLA, SILICEA, SINAPSIS ARVENSIS, FLOS, TABACUM | Healing Natural Oils LLC | 4ee5c82e-9edf-c36e-e063-6394a90a237f | 2026-04-07 | Warnings | 451W47IQ8X |
| Sodium Citrate and Citric Acid | SODIUM CITRATE AND CITRIC ACID | Chartwell Governmental & Specialty RX, LLC | 58c24504-47de-487a-ab8d-18add155ea95 | 2026-04-07 | Adverse reactions | 2968PHW8QP |
| Bupivacaine Spinal | BUPIVACAINE HYDROCHLORIDE IN DEXTROSE | Hospira, Inc. | 7a8d2539-4422-4312-0298-207ef1a2948e | 2026-04-07 | Warnings, Adverse reactions | 7TQO7W3VT8 |
| Walgreens Sodium Chloride Ophthalmic 5 Percent Hypertonicity Eye | SODIUM CHLORIDE | Walgreen Company | bda3b9db-5fc4-408c-a5ae-d1eeb3ee308d | 2026-04-06 | Warnings | 451W47IQ8X |
| BUPIVACAINE HYDROCHLORIDE | BUPIVACAINE HYDROCHLORIDE | Camber Pharmaceuticals, Inc. | 0e552e3a-cf52-4d74-9381-6cc1b29b4c90 | 2026-04-04 | Boxed warning, Warnings, Adverse reactions | 1724880 1724884 1725078 1725082 7TQO7W3VT8 |
| Sodium Chloride Ophthalmic 5 Percent Hypertonicity Eye | SODIUM CHLORIDE | Hanlim | 4ee80e16-1bb1-8238-e063-6294a90aa719 | 2026-04-04 | Warnings | 451W47IQ8X |
| BACTERIOSTATIC SODIUM CHLORIDE | SODIUM CHLORIDE | Hospira, Inc. | 376093e7-e09e-4a57-3199-195e45251866 | 2026-04-03 | Boxed warning, Warnings, Adverse reactions | 451W47IQ8X |
| Migraine and Headache | IRIS VERSICOLOR ROOT AND SODIUM CHLORIDE | Forces of Nature | 0dd2f2e2-78e2-435e-b7b2-ca590953ff94 | 2026-04-01 | Warnings | 451W47IQ8X |
| Cold Sore Formula | DULCAMARA, GLYCYRRHIZA GLABRA, RANUNCULUS BULBOSUS, RHUS TOX, NATRUM MURIATICUM, FAGOPYRUM ESCULENTUM, NATRUM MURIATICUM, ACONITUM NAPELLUS, CYTOMEGALOVIRUS NOSODE, HERPES SIMPLEX I AND II NOSODE, SEPIA, EPSTEIN BARR VIRUS NOSODE, HERPES ZOSTER NOSODE, ADENOVIREN NOSODE | Nutritional Specialties, Inc. | f4e7e469-baaf-4c61-af44-80b0832eadf0 | 2026-03-31 | Warnings | 451W47IQ8X |
| Sodium Chloride Normal Salt | SODIUM CHLORIDE | TWIN MED LLC | 10230c8a-e5e5-44f1-b41d-80930899d6b9 | 2026-03-31 | Warnings | 451W47IQ8X |
| H-Allergy Formula | ALLIUM CEPA, AMBROSIA ARTEMISIAEFOLIA, ARUM TRIPHYLLUM, ARUNDO MAURITANICA, EUPHRASIA OFFICINALIS, GALPHIMIA GLAUCA, HISTAMINUM HYDROCHLORICUM, KALI BICHROMICUM, NATRUM MURIATICUM, SOLIDAGO VIRGAUREA, STICTA PULMONARIA, SULPHUR, TRIFOLIUM PRATENSE, WYETHIA HELENIOIDES | Healing Natural Oils LLC | 4e586360-b3c4-1ce0-e063-6394a90ab6b8 | 2026-03-31 | Warnings | 451W47IQ8X |
| Flavalta | LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE | Septodont, Inc. | 3f9f9b4f-bf6c-4b57-ac1a-98fd1a9a369d | 2026-03-31 | Warnings, Adverse reactions | 30Q7KI53AK |
| Acne HP | CARBO ANIMALIS, CARBO VEGETABILIS, KALI BICHROMICUM, NATRUM MURIATICUM, PULSATILLA (VULGARIS), SEPIA, SILICEA, SULPHUR, ZINCUM METALLICUM | BioActive Nutritional, Inc. | 2ab4ff53-4274-40c7-b05c-44d918d809be | 2026-03-31 | Warnings | 451W47IQ8X |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.